JNJ
Johnson & Johnson's Q1 2025 Performance Shines with Strong Portfolio Pipeline and Record-Breaking Sales
Johnson & Johnson, a multinational healthcare company, recently reported its first-quarter results for 2025, showcasing impressive performance across its commercial, R&D, and supply chain capabilities. The company's Chairman and CEO, Joaquin Duato, described the period as a testament to their strength in execution and a reflection